Piramal Pharma Limited (NSE: PPLPHARMA)

India flag India · Delayed Price · Currency is INR
250.00
-1.75 (-0.70%)
Nov 21, 2024, 9:07 AM IST
109.03%
Market Cap 326.00B
Revenue (ttm) 87.04B
Net Income (ttm) 453.30M
Shares Out 1.33B
EPS (ttm) 0.34
PE Ratio n/a
Forward PE 72.93
Dividend 0.11 (0.04%)
Ex-Dividend Date Jul 12, 2024
Volume 4,256,596
Open 250.00
Previous Close 251.75
Day's Range 250.00 - 250.00
52-Week Range 114.35 - 307.90
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off... [Read more]

Sector Healthcare
Founded 2020
Employees 6,719
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.